Sponsor La Maison: Save lives, make a difference

Join us and become an essential part of saving the lives of sick children.

La Maison welcomes sick children, mainly from Africa, who have been transferred to Switzerland for treatment. The young patients stay with us and receive dedicated care before and after their hospital stays, until they are well enough to return home to their families.

Why sponsor La Maison?

Each sponsorship helps provide life-saving treatment for between 180 and 200 children brought to Switzerland every year.

Providing crucial medical support to the children

85% of the children we welcome suffer from heart disease. For more than 50 years, La Maison has been providing a warm welcome and care to these children before and after their operations at the university hospitals of Geneva (HUG) and Lausanne (CHUV), our long-standing partners.

Put your generosity into action!

Through your donations, you can turn cries for help into smiles. Every child welcomed at La Maison benefits from your support, transforming hope into healing.

At your complete discretion

Please note that the amount and frequency of your payments are entirely up to you. When you sign up to sponsor La Maison, you will receive annual payment slips with a reference number.

To avoid unnecessary costs, we don’t send our sponsors a thank you note for each payment, but you can request a receipt or acknowledgement of donation at any time. At the beginning of each year, you will receive a certificate for your tax return.

Children welcomed at La Maison

Action in accordance with the Rights of the Child

La Maison’s mission is fully aligned with the Rights of the Child. The Convention remains our benchmark for providing respectful care that honours the dignity of every child.

Stay connected with our work

As a valued sponsor, you will receive La Maison’s newsletter four times a year. Each edition of the newsletter offers a detailed overview of life at La Maison, stories about the children you support, and news about our partnerships and collaborations.